Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSC | P53634 | 20/20 | 0.57 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CTSH | P09668 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | CTSK | P43235 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31757699 | 0.87 | CTSC (0.57) | CTSCKCNH2CYP1A2CYP3A4CTSH | |
| SCHEMBL31758026 | 0.87 | CTSC (0.55) | CTSCKCNH2CYP1A2CYP3A4CTSH | |
| SCHEMBL31757698 | 0.87 | CTSC (0.57) | CTSCKCNH2CYP1A2CYP3A4CTSH | |
| SCHEMBL31757918 | 0.87 | CTSC (0.60) | CTSCKCNH2CYP1A2CYP3A4CTSH | |
| SCHEMBL31758139 | 0.86 | CTSC (0.51) | CTSCKCNH2CTSK | |
| SCHEMBL31758126 | 0.86 | CTSC (0.56) | CTSCKCNH2CYP1A2CYP3A4CTSH | |
| SCHEMBL31757783 | 0.85 | CTSC (0.59) | CTSCKCNH2CYP1A2CYP3A4CTSH | |
| SCHEMBL31758033 | 0.84 | CTSC (0.57) | CTSCKCNH2CYP1A2CYP3A4CTSH | |
| SCHEMBL31757697 | 0.83 | CTSC (0.53) | CTSCKCNH2CYP1A2CYP3A4CTSH | |
| SCHEMBL31757911 | 0.83 | CTSC (0.54) | CTSCKCNH2CYP1A2CYP3A4CTSH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260008758-A1 | LINEAR DIPEPTIDYL PEPTIDASE 1 INHIBITORS AND USES THEREOF | INSMED INCORPORATED | 2026-01-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260008758-A1 | LINEAR DIPEPTIDYL PEPTIDASE 1 INHIBITORS AND USES THEREOF | DPP3, DPP7, DPP9 | CTSC 6/4885KCNH2 1357/4885CYP1A2 1348/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.